Spots Global Cancer Trial Database for Metastatic Left Colon and Rectal Cancer Treatment With Anti_EGFR Targeted Therapy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Metastatic Left Colon and Rectal Cancer Treatment With Anti_EGFR Targeted Therapy

Official Title: Retrospective Study of Metastatic Left Colon and Rectal Cancer as Regard Treatment With Anti_EGFR Targeted Therapy

Study ID: NCT06083974

Conditions

Metastatic Colorectal Adenocarcinoma

Interventions

Study Description

Brief Summary: Colorectal cancer ranks the second lethal cancer and third prevalent malignant tumour worldwide, Despite of different odern modalities for diagnosis,large number of cases diagnosed at metastatic advanced stage . New treatment approach has been discovered habe been discovered making a huge revolution in metastatic colorectal cancer represented by targeted therapy including anti_EGFR ,anti_angiogenic and kinase inhibitors .

Detailed Description: Retrospective study aims to evaluate the effect of EGFR expression in metastatic colorectal cancer and the outcome of treatment with anti_EGFR targeted therapy between left colon and rectal cancer